Clinical Trials Directory

Trials / Unknown

UnknownNCT02242786

Diffusion-Weighted Magnetic Resonance Imaging

Response Assessment for External Beam Radiation Therapy in Spinal Metastasis of Hepatocellular Carcinoma (HCC): Usefulness of Diffusion-Weighted Magnetic Resonance (MR) Imaging as A Functional Imaging

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
17 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Recently, diffusion-weighted (DW) MR imaging has widened its application on various oncologic applications. Especially, it is expected the DW MRI could provide valuable information about early response evaluation after treatment using rapid apparent diffusion coefficient (ADC) value change. It has demonstrated potential usefulness in response evaluation in the liver tumors after treatments such as transarterial chemoembolization (TACE) and radiation therapy (RT). Furthermore, it is a functional imaging technique that does not require a contrast agent, it can be safely used in patients with renal insufficiency or other medical contraindications for contrast agents. The optimal assessment of early response of RT could provide one of the most important information to prescribe patient and cancer specific RT dose. It might be also important in palliative RT of HCC bone metastasis which is related with painful aggressive mass formation. This study is performed to evaluate the usefulness of DW MRI in early response evaluation after RT for HCC bone metastasis.

Conditions

Interventions

TypeNameDescription
RADIATIONExternal beam radiation therapy

Timeline

Start date
2014-08-01
Primary completion
2015-07-01
First posted
2014-09-17
Last updated
2014-11-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02242786. Inclusion in this directory is not an endorsement.